APA (7th ed.) Citation

Zhou, J., Zhong, L., Chowdhury, D., Skorobogatykh, K., Luo, G., Yang, X., . . . Yu, S. (2023, August). Galcanezumab in patients with episodic migraine: Results from the open-label period of the phase 3 PERSIST study. The Journal of Headache and Pain.

Chicago Style (17th ed.) Citation

Zhou, Jiying, et al. "Galcanezumab in Patients with Episodic Migraine: Results from the Open-label Period of the Phase 3 PERSIST Study." The Journal of Headache and Pain Aug. 2023.

MLA (9th ed.) Citation

Zhou, Jiying, et al. "Galcanezumab in Patients with Episodic Migraine: Results from the Open-label Period of the Phase 3 PERSIST Study." The Journal of Headache and Pain, Aug. 2023.